Benefit

Home ▶ Benefit
ATS Foundation Research Program Benefit

The ATS Foundation Research Program Benefit is the premier networking reception held during the ATS International Conference. It attracts international leaders across the respiratory spectrum, and is a key source of unrestricted research grants the Foundation awards to young investigators in pulmonary, critical care, and sleep medicine.

For more information on benefit corporate or institutional packages, please contact Lara Endreszl at lendreszl@thoracic.org.

For more information on benefit academic medical institution, nonprofit organization, or individual group packages, please contact Ally Felix at afelix@thoracic.org.


Save the date! Benefit 2019

Sharon Rounds, MD, the 2019
Breathing for Life Awardee

We hope to see you there!

  • Network with friends and colleagues
  • Enjoy live music and delicious food catered by Wolfgang Puck Catering
  • Honor the ATS Foundation Breathing for Life Awardee and the Research Program awardees
  • Support the ATS Foundation Research Program—and launch careers dedicated to scientific discovery and better patient care

We offer two ways to participate:

  • Reserved seating ensures your group has its own space, as well as network the event.
  • Unreserved seating allows you entry to the benefit, but your seating is not reserved.

You can register for the benefit with your ATS 2019 registration when conference registration opens early December.


James F. Donohue, MD, the 2018 Awardee

The Breathing for Life Award is the highest honor given by the Foundation for philanthropy, scientific achievement, and commitment to mentorship. Breathing for Life Award recipients include:


Photo albums:

Photos from the 2018 Benefit, which honored James Donohue, MD with the Breathing for Life Award

Photos from the 2017 Benefit, which honored David Center, MD 

Photos from the 2016 Benefit, which honored Sally Wenzel, MD 

Photos from the 2015 Benefit, which honored Marvin Schwarz, MD

Photos from the 2014 Benefit, which honored William Busse, MD

Plus, read more about the 2017 Benefit


The ATS Foundation thanks Genentech for support at the Sapphire Level for the Tenth Annual ATS Foundation Research Program Benefit; AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc. at the Gold Level; Freeman, Gilead Sciences, Inc., Insmed Incorporated, Mallinckrodt Pharmaceuticals, Sunovion Pharmaceuticals, Inc., and Theravance at the Silver Level; Ascend Integrated Media, Circassia Pharmaceuticals, Grifols, GlaxoSmithKline, NBRC, Novartis, and Vertex Pharmaceuticals, Inc. at the Bronze Level.

The ATS Foundation also thanks the many individuals and medical institutions that have stepped forward to support the Research Program and young investigators in pulmonary, critical care, and sleep medicine.


The ATS supports the ATS Foundation’s administrative expenses, assuring that every dollar contributed goes directly to support programs. 

Donate